Business
Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase
PARSIPPANY, N.J., December 11, 2025--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the first quarter of 2026, an increase of 6% from the quarterly dividend rate paid in 2025. The dividend will be paid on Tuesday, March 3, 2026, to all holders of record of the Company’s common stock as of the close of business on Tuesday, January 20, 2026.
About this update from Zoetis Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1035,"height":387,"url":"https://media.zenfs.com/en/business-wire.com/ce2edd55d0e85638e4c3596abfd63099"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/tifJy4nNIOyfazH1v.jNGg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM1OTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/ce2edd55d0e85638e4c3596abfd63099","width":960,"height":359},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/xG8egrXbZNwnTZ52M5H_Mw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNzA7aD03NzQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/ce2edd55d0e85638e4c3596abfd63099","width":1035,"height":387}},"lazy":false},{"type":"text","content":"PARSIPPANY, N.J., December 11, 2025--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the first quarter of 2026, an increase of 6% from the quarterly dividend rate paid in 2025. The dividend will be paid on Tuesday, March 3, 2026, to all holders of record of the Company’s common stock as of the close of business on Tuesday, January 20, 2026.","length":407,"tagName":"p"},{"type":"text","content":"About Zoetis","length":12,"tagName":"p"},{"type":"text","content":"As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide -- from veterinarians and pet owners to livestock producers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees. For more information, visit www.zoetis.com.","length":680,"tagName":"p"},{"type":"text","content":"DISCLOSURE NOTICES","length":18,"tagName":"p"},{"type":"text","content":"Forward-Looking Statements: This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.","length":170,"tagName":"p"},{"type":"text","content":"These forward-looking statements include, but are not limited...